Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-14

FDA Approved: RISPERIDONE — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

The FDA approved a supplemental application for risperidone from Zydus Lifesciences Limited. This action authorizes a supplemental approval for the generic prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

SUPPL AP for RISPERIDONE (RISPERIDONE)